Document is current
Any future updates will be listed below
-
Authors
Nambu, Ryusuke https://orcid.org/0000-0002-7206-7111
Arai, Katsuhiro
Kudo, Takahiro
Murakoshi, Takatsugu
Kunisaki, Reiko
Mizuochi, Tatsuki
Kato, Sawako
Kumagai, Hideki
Inoue, Mikihiro
Ishige, Takashi
Saito, Takeshi
Noguchi, Atsuko
Yodoshi, Toshifumi
Hagiwara, Shin-Ichiro
Iwata, Naomi
Nishimata, Shigeo
Kakuta, Fumihiko
Tajiri, Hitoshi
Hiejima, Eitaro
Toita, Nariaki
Mochizuki, Takahiro
Shimizu, Hirotaka
Iwama, Itaru
Hirano, Yuri
Shimizu, Toshiaki
,
-
Funding
Funding for this research was provided by:
Ministry of Health, Labour and Welfare
- License Information
-
More Information
Article History
Received: 30 December 2022
Accepted: 14 February 2023
First Online: 8 March 2023
Declarations
:
: KA has received grant support from Nippon Kayaku Co., Ltd. and received consulting and lecture fees from Mitsubishi Tanabe Pharma Corporation, Janssen Pharmaceutical K.K., EA Pharma Co., Ltd., AbbVie GK, Kyorin Pharmaceutical Co., Ltd., Nippon Kayaku Co., Ltd., Takeda Pharmaceutical Co., Ltd., Kissei Pharmaceutical Co., Ltd, and Eli Lilly Japan K.K. TMi has received lecture fees from AbbVie GK, EA Pharma Co., Ltd., Takeda Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, and Kyorin Pharmaceutical Co., Ltd. SIH has received lecture fees from AbbVie GK, Mitsubishi Tanabe Pharma Corporation. RN, TKu, TMu, RK, SK, HK, MI, TI, TS, AN, TY, NI, SN, FK, HT, EH, NT, TMo, HS, II, YH and TS have no conflicts of interest.
